F
Flowonix
Medical device company developing solutions for patients with chronic disorders
About Flowonix
Flowonix Medical Inc. is dedicated to advancing targeted drug delivery systems aimed at treating neurological disorders. The company focuses on designing, developing, and deploying patient-centric drug delivery platforms that provide physicians with optimal solutions for managing their patients' conditions. Operating in the medical technology market, Flowonix serves healthcare providers and patients who require specialized treatment for chronic pain and other neurological issues. The business model revolves around continuous research and development, ensuring that their products remain at the forefront of medical innovation. Flowonix generates revenue through the sale of its advanced drug delivery systems to healthcare institutions and practitioners. The company is headquartered in Mt. Olive, New Jersey, and remains committed to improving patient outcomes through cutting-edge technology.
Source: Dealroom company dataAt a glance
- Founded
- 2005
- Headquarters
- Mount Olive, United States
- Sector
- Biotech & Life Sciences
Knowledge graph
More headlines
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A2 investors entered at this stage
- JFJoe W. And Dorothy Dorsett Brown Foundation
Farallon Capital Management
Series B and later3 investors entered at this stage
Clarus Ventures- RCRFT Investment Company
Hercules Capital
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Flowonix on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Flowonix on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.